Wilma Fowler Bergfeld

Wilma Fowler Bergfeld's AcademicInfluence.com Rankings

Medical

#2335

World Rank

#2753

Historical Rank

Dermatology

#44

World Rank

#60

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Wilma Fowler Bergfeld Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Wilma Fowler Bergfeld's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. (1998) (540)
Pyoderma gangrenosum: a review. (1988) (364)
Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001. (2003) (325)
Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. (1971) (254)
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. (2000) (249)
Evaluation and treatment of male and female pattern hair loss. (2005) (223)
The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. (2006) (214)
Psoriasis-liver-methotrexate interactions. (1973) (211)
Androgenetic Alopecia: An Evidence-Based Treatment Update (2014) (174)
A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. (2007) (168)
Efficacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-controlled, Double-blind Study (2014) (147)
Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. (1999) (124)
Final Report of the Safety Assessment of Kojic Acid as Used in Cosmetics (2010) (117)
Final Report of the Safety Assessment of Hyaluronic Acid, Potassium Hyaluronate, and Sodium Hyaluronate (2009) (112)
Diffuse hair loss: Its triggers and management (2009) (99)
A case-series of 29 patients with lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment. (2007) (96)
Androgenetic alopecia: an autosomal dominant disorder. (1995) (95)
Indirect immunofluorescence on rat bladder transitional epithelium: a test with high specificity for paraneoplastic pemphigus. (1993) (95)
Histopathologic Evaluation of Alopecias (2006) (94)
Squamous cell carcinoma of the nail bed: a clinicopathological study of 12 cases (1990) (92)
Hepatotoxicity of methotrexate in the treatment of psoriasis. (1971) (88)
Medical and environmental risk factors for the development of central centrifugal cicatricial alopecia: a population study. (2011) (87)
The utility of cytokeratin 5/6 in the recognition of cutaneous spindle cell squamous cell carcinoma (2001) (85)
Final Report of the Safety Assessment of Methylisothiazolinone (2010) (84)
A retrospective biopsy study of the clinical diagnostic accuracy of common skin diseases by different specialties compared with dermatology. (2005) (82)
Finasteride in the treatment of alopecia (2004) (79)
The clinical evaluation of hirsutism (2008) (77)
Treatment of Alopecia Areata With Tofacitinib (2017) (76)
Malignant melanoma arising in a blue nevus with features of pilar neurocristic hamartoma (1993) (75)
A histologic review of 27 patients with lichen planopilaris. (2008) (75)
Safety Assessment of Propylene Glycol, Tripropylene Glycol, and PPGs as Used in Cosmetics (2012) (73)
α-Hydroxy Acid-Based Cosmetic Procedures (2000) (73)
Cicatricial alopecia: classification and histopathology (2008) (72)
Elastic tissue in scars and alopecia (2000) (68)
Scleromyxedema associated with scleroderma renal disease and acute psychosis. (1986) (66)
Central hair loss in African American women: incidence and potential risk factors. (2011) (64)
Malignant angioendotheliomatosis: an angiotropic lymphoma. (1989) (62)
Safety of ingredients used in cosmetics. (2005) (62)
The Alopecia Areata Consensus of Experts (ACE) Study: Results of an International Expert Opinion on Treatments for Alopecia Areata. (2020) (61)
Eosinophilic cellulitis and eosinophilic pustular folliculitis. (1989) (61)
Eosinophilic cellulitis associated with urticaria. A report of two cases. (1986) (60)
Relapsing polychondritis. Immunomicroscopic findings in cartilage of ear biopsy specimens. (1980) (59)
A light microscopic and immunohistochemical evaluation of scars (2002) (59)
Proceedings from the national conference to develop a national skin cancer agenda. American Academy of Dermatology and Centers for Disease Control and Prevention, April 8-10, 1995. (1996) (56)
Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail. (1998) (55)
Hair: what is new in diagnosis and management? Female pattern hair loss update: diagnosis and treatment. (2013) (55)
Amiodarone-induced linear IgA disease. (1994) (52)
Pretibial mucin. Histologic patterns and clinical correlation. (1993) (51)
Final Amended Safety Assessment of Hydroquinone as Used in Cosmetics (2010) (49)
Evaluation of a new paraffin-reactive CD7 T-cell deletion marker and a polymerase chain reaction-based T-cell receptor gene rearrangement assay: implications for diagnosis of mycosis fungoides in community clinical practice. (2001) (48)
Grover disease (transient acantholytic dermatosis). (2009) (48)
Final Report of the Amended Safety Assessment of Sodium Laureth Sulfate and Related Salts of Sulfated Ethoxylated Alcohols (2010) (48)
Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients. (2015) (48)
Safety Assessment of Cyclomethicone, Cyclotetrasiloxane, Cyclopentasiloxane, Cyclohexasiloxane, and Cycloheptasiloxane (2011) (47)
Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. (2019) (47)
Sports dermatology. (1998) (47)
Contact leukoderma associated with the use of hair colors. (1993) (47)
The evaluation and management of acne: economic considerations. (1995) (47)
Full proceedings from the National Conference to Develop a National Skin Cancer Agenda. American Academy of Dermatology and Centers for Disease Control and Prevention, Washington, D.C., April 8-10, 1995. (1996) (47)
Lichen planus associated with neoplasia: a cell-mediated immune response to tumor antigens? (1994) (46)
Safety Assessment of Glycerin as Used in Cosmetics (2019) (45)
Central scalp alopecia photographic scale in African American women (2008) (45)
Trauma, sports, and the skin. (1985) (44)
Squamous cell carcinoma arising from the follicular occlusion triad. (1996) (44)
The use of oral pioglitazone in the treatment of lichen planopilaris. (2015) (44)
Reticulate pigmented anomaly of the flexures (Dowling-Degos disease): a case report associated with hidradenitis suppurativa and squamous cell carcinoma. (1990) (43)
Safety Assessment of Citric Acid, Inorganic Citrate Salts, and Alkyl Citrate Esters as Used in Cosmetics (2014) (43)
Final Report of the Cosmetic Ingredient Review Expert Panel Amended Safety Assessment of Calendula officinalis—Derived Cosmetic Ingredients (2010) (43)
Final Report on the Safety Assessment of Cocos nucifera (Coconut) Oil and Related Ingredients (2011) (42)
Patient-perceived importance of negative effects of androgenetic alopecia in women. (1999) (42)
Androgenetic alopecia and risk of prostate cancer: a systematic review and meta-analysis. (2013) (42)
Perforating granuloma annulare in a patient with acquired immunodeficiency syndrome. Immunohistologic evaluation of the cellular infiltrate. (1987) (42)
alpha-Hydroxy acid-based cosmetic procedures. Guidelines for patient management. (2000) (41)
Primary cutaneous coccidioidomycosis. (2003) (41)
Long-Term Efficacy and Safety of Tretinoin Emollient Cream 0.05% in the Treatment of Photodamaged Facial Skin (2005) (40)
Adrenal androgenic female-pattern alopecia: sex hormones and the balding woman. (1983) (40)
Quantitative Analysis of Eosinophils in Acute Graft-Versus-Host Disease Compared With Drug Hypersensitivity Reactions (2010) (39)
Eosinophils in fibrous tracts and near hair bulbs: a helpful diagnostic feature of alopecia areata. (1997) (39)
Epithelioid sarcoma: an immunohistochemical analysis evaluating the utility of cytokeratin 5/6 in distinguishing superficial epithelioid sarcoma from spindled squamous cell carcinoma (2003) (39)
Familial Cutaneous Mastocytosis (2001) (39)
Tretinoin cream 0.02% for the treatment of photodamaged facial skin: a review of 2 double-blind clinical studies. (2001) (39)
Ehlers-Danlos syndrome type IV: a single base substitution of the last nucleotide of exon 34 in COL3A1 leads to exon skipping. (1995) (39)
Prevalence of hormonal and endocrine dysfunction in patients with lichen planopilaris (LPP): A retrospective data analysis of 168 patients (2017) (38)
Reticulate pigmented anomaly of the flexures (1991) (38)
Safety Assessment of Microbial Polysaccharide Gums as Used in Cosmetics (2016) (38)
A systemic type I 5 α-reductase inhibitor is ineffective in the treatment of acne vulgaris (2004) (38)
Update on cicatricial alopecia. (2003) (38)
Safety Assessment of Benzyl Alcohol, Benzoic Acid and its Salts, and Benzyl Benzoate (2017) (37)
Shedding: how to manage a common cause of hair loss. (2001) (37)
Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome (2016) (37)
Safety Assessment of Decyl Glucoside and Other Alkyl Glucosides as Used in Cosmetics (2013) (37)
Development of a health‐related quality of life questionnaire for women with androgenetic alopecia (2000) (36)
Cutaneous presentation of posttransplant lymphoproliferative disorder. (2000) (36)
A lifetime of healthy skin: implications for women. (1999) (36)
Safety Assessment of Triethanolamine and Triethanolamine-Containing Ingredients as Used in Cosmetics (2013) (36)
Safety Assessment of Vitis vinifera (Grape)-Derived Ingredients as Used in Cosmetics (2014) (35)
Magnetic resonance imaging of cutaneous neoplasms: clinicopathologic correlation. (1991) (35)
Safety Assessment of Talc as Used in Cosmetics (2015) (35)
Alopecia areata is a medical disease. (2018) (35)
Metastatic transitional cell carcinoma mimicking zoster sine herpete. (1986) (35)
Towards a consensus on how to diagnose and quantify female pattern hair loss – The ‘Female Pattern Hair Loss Severity Index (FPHL‐SI)’ (2016) (35)
Central centrifugal cicatricial alopecia – an approach to diagnosis and management (2011) (34)
Final Report of the Safety Assessment of Allantoin and Its Related Complexes (2010) (34)
Objective outcome measures: Collecting meaningful data on alopecia areata (2017) (33)
Extensive alopecia areata. Results of treatment with 3% topical minoxidil. (1989) (33)
Comorbidities in patients with alopecia areata (2017) (33)
Safety Assessment of 1,2-Glycols as Used in Cosmetics (2012) (32)
Pseudallescheria boydii in an immunocompromised host. Successful treatment with debridement and itraconazole. (1996) (32)
Improving the cosmetic appearance of photoaged skin with glycolic acid. (1997) (32)
The pathophysiology of acne vulgaris in children and adolescents, Part 1. (2004) (31)
Prevalence of atopic comorbidities in eosinophilic esophagitis: A case‐control study of 449 patients (2017) (29)
Updates in therapeutics for folliculitis decalvans: A systematic review with evidence‐based analysis (2019) (29)
The treatment of keratosis palmaris et plantaris with isotretinoin. A multicenter study. (1982) (29)
Fluoroscopy‐induced chronic radiation dermatitis: a report of two additional cases and a brief review of the literature (2012) (29)
Fibrous papule of the nose with granular cells: two cases (1991) (28)
A Four‐Year Pathology Review of the Near Total Face Transplant (2013) (28)
Association of lichen planopilaris with thyroid disease: a retrospective case-control study. (2014) (28)
Safety Assessment of α-Amino Acids as Used in Cosmetics (2013) (28)
Final Report of the Amended Safety Assessment of Myristic Acid and Its Salts and Esters as Used in Cosmetics (2010) (27)
Ultraviolet Light and Skin Cancer in Athletes (2009) (27)
Hypopigmentation in frontal fibrosing alopecia (2017) (27)
Safety Assessment of Alumina and Aluminum Hydroxide as Used in Cosmetics (2016) (26)
Safety Assessment of Plant-Derived Fatty Acid Oils (2017) (26)
Final Report of the Cosmetic Ingredient Review Expert Panel on the Safety Assessment of Cocamidopropyl betaine (CAPB) (2012) (26)
Basal cell carcinoma with monster cells (1993) (25)
A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris. (2004) (25)
A morphologic study of dermatofibrosarcoma protuberans: expansion of a histologic profile (2000) (25)
Amended Safety Assessment of Parabens as Used in Cosmetics (2020) (24)
The combined utilization of clinical and histological findings in the diagnosis of trichotillomania (2002) (24)
Carcinoma erysipelatoides resulting from genitourinary cancer. (1996) (23)
Treatment of androgenic disorders with dexamethasone: dose-response relationship for suppression of dehydroepiandrosterone sulfate. (1990) (23)
Safety Assessment of Boron Nitride as Used in Cosmetics (2015) (23)
Executive summary of the national "Sun Safety: Protecting Our Future" Conference: American Academy of Dermatology and Centers for Disease Control and Prevention. New York, New York, May 1 and 2, 1997. (1998) (23)
5‐alpha‐reductase inhibitor treatment for frontal fibrosing alopecia: an evidence‐based treatment update (2018) (23)
Diagnostic approach to androgen disorders in women: acne, hirsutism, and alopecia. (1990) (23)
Final Report of the Cosmetic Ingredient Review Expert Panel on the Safety Assessment of Dicarboxylic Acids, Salts, and Esters (2012) (22)
Fiber implantation for pattern baldness. (1979) (22)
Muir-Torre syndrome associated with α1-antitrypsin deficiency and cutaneous vasculitis (1991) (22)
Final Report of the Cosmetic Ingredient Review Expert Panel Safety Assessment of Polymethyl Methacrylate (PMMA), Methyl Methacrylate Crosspolymer, and Methyl Methacrylate/Glycol Dimethacrylate Crosspolymer (2011) (22)
Langerhans cell collections, but not eosinophils, are clues to a diagnosis of allergic contact dermatitis in appropriate skin biopsies (2016) (22)
Long-term implications of T-cell receptor gene rearrangement analysis by Southern blot in patients with cutaneous T-cell lymphoma. (2003) (22)
Microcystic Adnexal Carcinoma (MAC) of the Scalp with Extensive Pilar Differentiation (2002) (22)
Persistent Annular Erythema of Infancy (1993) (21)
Prevalence of Comorbid Conditions and Sun-Induced Skin Cancers in Patients with Alopecia Areata. (2015) (21)
Hair loss: an overview. (2001) (21)
Safety Assessment of Amino Acid Alkyl Amides as Used in Cosmetics (2017) (21)
Relapsing polychondritis with positive direct immunofluorescence. (1978) (21)
Amended Safety Assessment of Formaldehyde and Methylene Glycol as Used in Cosmetics (2013) (20)
Pyoderma gangrenosum responsive to minocycline hydrochloride. (1978) (20)
Safety Assessment of Alkyl Esters as Used in Cosmetics (2015) (20)
Morphologic mimickers of Cryptococcus occurring within inflammatory infiltrates in the setting of neutrophilic dermatitis: a series of three cases highlighting clinical dilemmas associated with a novel histopathologic pitfall (2013) (20)
Safety Assessment of Rosmarinus officinalis (Rosemary)-Derived Ingredients as Used in Cosmetics (2018) (20)
Update on the management of hirsutism (2010) (20)
Malignant melanoma and Charcot-Marie-Tooth disease. (1980) (20)
Cutaneous macroglobulinosis. (1980) (20)
Safety Assessment of Tocopherols and Tocotrienols as Used in Cosmetics (2018) (19)
Final Report of the Cosmetic Ingredient Review Expert Panel on the Safety Assessment of Pelargonic Acid (Nonanoic Acid) and Nonanoate Esters (2011) (19)
Soft‐tissue perineurioma in a 20‐year‐old patient with neurofibromatosis type 1 (NF1): report of a case and review of the literature (2007) (19)
Palmar-plantar hyperhidrosis occurring in a kindred with nail-patella syndrome. (1980) (19)
Expression profile and molecular genetic regulation of cyclin D1 expression in epithelioid sarcoma (2005) (19)
Cicatricial Alopecia Research Foundation meeting, May 2016: Progress towards the diagnosis, treatment and cure of primary cicatricial alopecias (2018) (19)
Common and Uncommon Dermatologic Diseases Related to Sports Activities (1988) (19)
Safety Assessment of Trimoniums as Used in Cosmetics (2012) (19)
Amended Safety Assessment of Methylisothiazolinone as Used in Cosmetics (2019) (19)
Globular deposits of immunoglobulins and complement in the papillary dermis. Clinical significance. (1980) (19)
Treatment of androgenic disorders in women: acne, hirsutism, and alopecia. (1990) (18)
"Lesion," "rule out...," and other vagaries of filling out pathology requisition forms. (2005) (18)
Relapsing polychondritis: a case diagnosed by direct immunofluorescence and coexisting with pseudocyst of the auricle. (1992) (18)
Metastatic gastric adenocarcinoma presenting as an enlarging plaque on the scalp. (2005) (18)
Safety Assessment of Alkyl Benzoates as Used in Cosmetics (2012) (18)
Pathological case of the month (1996) (18)
Retinoids and hair growth. (1998) (18)
Seborrheic keratoses with occult underlying basal cell carcinoma. (1993) (18)
The Alopecia Areata Consensus of Experts (ACE) Study PART II: Results of an International Expert Opinion on Diagnosis and Laboratory Evaluation for Alopecia Areata. (2020) (18)
Stevens-Johnson syndrome associated with topical nitrogen mustard therapy. (1997) (17)
Treatment of pediatric alopecia areata with anthralin: A retrospective study of 37 patients (2018) (17)
Final Report of the Safety Assessment of Cosmetic Ingredients Derived From Zea Mays (Corn) (2011) (17)
Dermatologic problems in athletes. (1984) (17)
Final report on the safety assessment of Basic Violet 1, Basic Violet 3, and Basic Violet 4. (2009) (17)
Treatment with benzoyl peroxide of ulcers on legs within lesions of necrobiosis lipoidica diabeticorum. (1978) (16)
The Side Effects of Hair Products on the Scalp and Hair (1981) (16)
Hair camouflage: A comprehensive review (2016) (16)
Mucous gland basement membrane immunofluorescence in cicatricial pemphigoid. (1988) (16)
Eccrine angiomatous hamartoma in a neurofibromatosis type-1 patient. (2002) (16)
Syringomas on the Penis (1990) (16)
Topical minoxidil reduces blood pressure. (1985) (16)
Treatment of oral lichen planus with low-dose isotretinoin (1984) (16)
Safety assessment of alkyl PEG ethers as used in cosmetics. (2012) (15)
Safety Assessment of Hydrolyzed Wheat Protein and Hydrolyzed Wheat Gluten as Used in Cosmetics (2018) (15)
Final Amended Report on the Safety Assessment of Ammonium Thioglycolate, Butyl Thioglycolate, Calcium Thioglycolate, Ethanolamine Thioglycolate, Ethyl Thioglycolate, Glyceryl Thioglycolate, Isooctyl Thioglycolate, Isopropyl Thioglycolate, Magnesium Thioglycolate, Methyl Thioglycolate, Potassium Thio (2009) (15)
Urticarial Vasculitis in Adults (1988) (15)
Final Amended Report of the Safety Assessment of Toluene-2,5-Diamine, Toluene-2,5-Diamine Sulfate, and Toluene-3,4-Diamine as Used in Cosmetics (2010) (15)
Final Report of the Cosmetic Ingredient Review Expert Panel on the Safety Assessment of Methyl Acetate (2012) (15)
Hair camouflage: A comprehensive review☆ (2017) (15)
HLA-DR antigens in alopecia areata. Preliminary report. (1986) (15)
Hair regrowth in a male patient with extensive androgenetic alopecia on estrogen therapy. (2012) (15)
The role of immunosuppression in squamous cell carcinomas arising in seborrheic keratosis (2017) (14)
Schwannoma with sweat duct differentiation (1993) (14)
Final Amended Report on Safety Assessment on Aminomethyl Propanol and Aminomethyl Propanediol (2009) (14)
Vitamin D Status in Scarring and Non-Scarring Alopecia. (2018) (14)
Prevalence of cardiac and metabolic diseases among patients with alopecia areata (2020) (14)
Serum and blister‐fluid elevation and decreased epidermal content of high‐mobility group box 1 protein in drug‐induced Stevens–Johnson syndrome/toxic epidermal necrolysis† (2019) (14)
Safety Assessment of Galactomannans as Used in Cosmetics (2015) (14)
Comorbid conditions in lichen planopilaris: A retrospective data analysis of 334 patients☆ (2018) (14)
Role of the argon laser in treatment of lymphocytoma cutis. (1986) (14)
The pathophysiology of acne vulgaris in children and adolescents, part 2: Tailoring treatment. (2004) (14)
Trichilemmoma and syringocystadenoma papilliferum arising in naevus sebaceous. (2002) (14)
Safety Assessment of Alkyl Glyceryl Ethers as Used in Cosmetics (2013) (14)
Safety Assessment of Citrus-Derived Peel Oils as Used in Cosmetics (2019) (14)
Safety Assessment of PEGylated Oils as Used in Cosmetics (2014) (14)
Final Report of the Amended Safety Assessment of PVM/MA Copolymer and Its Related Salts and Esters as Used in Cosmetics (2011) (14)
Bullous Systemic Lupus Erythematosus (1989) (14)
Final Report on the Safety Assessment of Sodium Cetearyl Sulfate and Related Alkyl Sulfates as Used in Cosmetics (2010) (14)
GENERALIZED NON‐LANGERHANS CELL HISTIOCYTOSIS: FOUR CASES ILLUSTRATE A SPECTRUM OF DISEASE (1995) (13)
Granuloma Annulare Associated with Metastatic Adenocarcinoma (1991) (13)
Safety Assessment of Alkyl PEG/PPG Ethers as Used in Cosmetics (2012) (13)
Safety Assessment of Chlorphenesin as Used in Cosmetics (2014) (13)
A Phase III, Multicenter, Parallel-Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam Versus Vehicle in Women With Female Pattern Hair Loss. (2016) (13)
Alopecia areata: what to expect from current treatments. (2005) (13)
The aging skin. (1997) (13)
Cutaneous blastomycosis. Report of a case presumably acquired by direct inoculation and treated with carbon dioxide laser vaporization. (1987) (13)
Inadequate biopsy technique and specimen size: an alarming trend that compromises patient care and an appeal to our clinical colleagues. (2010) (13)
Safety Assessment of Silk Protein Ingredients as Used in Cosmetics (2020) (13)
Chemical and traumatic alopecia from thioglycolate in a black woman: a case report with unusual clinical and histologic findings. (1992) (13)
Male and female pattern hair loss: Treatable and worth treating (2021) (12)
Safety Assessment of Alkyl Betaines as Used in Cosmetics (2018) (12)
UNMASKING THE PRESENCE OF CIRCULATING PEMPHIGUS ANTIBODIES IN A PATIENT WITH COEXISTENT PEMPHIGUS, SLE, MULTIPLE AUTOANTIBODIES, AND GASTRIC CARCINOMA (1993) (12)
Advancement of women in dermatology (2011) (12)
Executive summary of the national Partners in Prevention Skin Cancer Conference: American Academy of Dermatology and Centers for Disease Control and Prevention. (1997) (12)
Aluminum tattoo: a phenomenon that can resemble parasitized histiocytes (1993) (12)
Safety Assessment of Tripeptide-1, Hexapeptide-12, Their Metal Salts and Fatty Acyl Derivatives, and Palmitoyl Tetrapeptide-7 as Used in Cosmetics (2018) (12)
Systemic and Light Therapies for the Management of Childhood Psoriasis: Part II (2008) (12)
Perforating pilomatricoma: a case report. (1989) (12)
Evaluation of surgical margins in melanocytic lesions: a survey among 152 dermatopathologists (2005) (12)
Diseases of the hair and nails. (2009) (12)
Virilization secondary to topical testosterone. (1991) (12)
Safety Assessment of Cucumis sativus (Cucumber)-Derived Ingredients as Used in Cosmetics (2014) (12)
OCCULT SYRINGOMA ASSOCIATED WITH ALOPECIA (1992) (12)
Hirsutism in Women: Effective Therapy that is Safe for Long-Term Use (2000) (12)
Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis. (2015) (12)
Development of the Alopecia Areata Scale for Clinical Use: Results of an Academic-Industry Collaborative Effort. (2021) (11)
Safety Assessment of PEGylated Alkyl Glycerides as Used in Cosmetics (2020) (11)
Amended Final Safety Assessment Benzyl Alcohol, and Benzoic Acid and its Salts and Benzyl Ester (2011) (11)
Final report on the safety assessment of amino nitrophenols as used in hair dyes. (2009) (11)
Cosmetic use of alpha-hydroxy acids. (1997) (11)
Reticulate Nonmelanocytic Hyperpigmentation Anomaly (1991) (11)
Face Transplantation for Granulomatosis With Polyangiitis (Wegener Granulomatosis): Technical Considerations, Immunological Aspects, and 3-Year Posttransplant Outcome (2019) (11)
Tumor cell characterization of histiocytic medullary reticulosis. (1977) (11)
Preferentially expressed antigen in melanoma and p16 expression in acral melanocytic neoplasms (2021) (10)
Amended Safety Assessment of Methylchloroisothiazolinone and Methylisothiazolinone as Used in Cosmetics (2021) (10)
Pathological case of the month. Congenital dermatofibrosarcoma protuberans. (1996) (10)
Contact dermatitis to knee patch adhesive in boys' jeans: a nonoccupational cause of epoxy resin sensitivity. (1983) (10)
Acquired uncombable hair. (1993) (10)
Safety Assessment of Isoparaffins as Used in Cosmetics (2012) (10)
A proposed classification for follicular involvement by melanoma (2017) (10)
Exophytic (Pedunculated) Malignant Melanoma— Cleveland Clinic Experience (1980) (10)
Clinical efficacy of diphenylcyclopropenone in alopecia areata: retrospective data analysis of 50 patients. (2014) (10)
Amended Safety Assessment of Dodecylbenzenesulfonate, Decylbenzenesulfonate, and Tridecylbenzenesulfonate Salts as Used in Cosmetics (2010) (10)
Alopecia: histologic changes. (1989) (10)
Safety Assessment of Diethanolamine and Its Salts as Used in Cosmetics (2017) (10)
Amended Safety Assessment of Sesamum Indicum (Sesame) Seed Oil, Hydrogenated Sesame Seed Oil, Sesamum Indicum (Sesame) Oil Unsaponifiables, and Sodium Sesameseedate (2011) (10)
Differences in biopsy techniques of actinic keratoses by plastic surgeons and dermatologists: a histologically controlled pilot study. (2006) (10)
LONG-TERM TREATMENT WITH TOFACITINIB IN SEVERE ALOPECIA AREATA: AN UPDATE. (2019) (10)
Colocalization of vitiligo and alopecia areata presenting as poliosis (2015) (10)
Iron deficiency and hair loss--nothing new? (2011) (9)
A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS). (2021) (9)
The Cosmetic Ingredient Review Program—Expert Safety Assessments of Cosmetic Ingredients in an Open Forum (2017) (9)
Pagetoid Spitz nevi: clinicopathologic characterization of a series of 12 cases (2016) (9)
Role of graft‐versus‐host disease in the development of secondary skin cancers in hematopoietic stem cell transplant recipients: A meta‐analysis (2018) (9)
Mixed Versus Pure Variants of Desmoplastic Melanoma: The Cleveland Clinic Experience (2017) (9)
Erythema elevatum diutinum a rare and poorly understood cutaneous vasculitis: A single institution experience (2018) (9)
Final Safety Assessment of Thiodipropionic Acid and Its Dialkyl Esters as Used in Cosmetics (2010) (9)
Safety Assessment of Modified Terephthalate Polymers as Used in Cosmetics (2014) (9)
Disseminated cutaneous fungal infection and AIDS. (1990) (9)
Safety Assessment of Achillea millefolium as Used in Cosmetics (2016) (9)
Skin diseases of football and wrestling participants. (1977) (9)
Interleukin-3-induced urticaria-like eruption. (1996) (9)
Association of Lichen Planopilaris With Dyslipidemia (2018) (9)
DIFFUSE INTRAEPIDERMAL DEPOSITION OF IMMUNOREACTANTS ON DIRECT IMMUNOFLUORESCENCE: A CLUE TO THE EARLY DIAGNOSIS OF EPIDERMAL NECROLYSIS (1994) (8)
Human papillomavirus-induced verrucous carcinoma of the mouth. Case report of an aggressive tumor. (1993) (8)
Safety Assessment of Dimethicone Crosspolymers as Used in Cosmetics (2014) (8)
The utility of using immunohistochemistry in the differentiation of metastatic, cutaneous clear cell renal cell carcinoma and clear cell hidradenoma (2017) (8)
Pretibial myxedema (elephantiasic form): treatment with cytotoxic therapy. (1983) (8)
Final Report of the Amended Safety Assessment of Quaternium-15 as Used in Cosmetics (2010) (8)
Acneiform Papules on the Neck (1995) (8)
Tretinoin emollient cream 0.01% for the treatment of photoaged skin. (1993) (8)
Hair loss: diagnosis and management. (2003) (8)
Vascular nodules and plaques resembling chronic mucocutaneous candidiasis in a patient with a low interleukin 2 level. (1993) (8)
Acute purpura fulminans—a rare cause of skin necrosis: A single‐institution clinicopathological experience (2020) (8)
When to ask your dermatopathologist to evaluate for surgical margins and when not: a matter of confusion for dermatologists and dermatopathologists alike. (2005) (7)
Cutaneous intravascular extramedullary hematopoiesis in a patient with post-polycythemia vera myelofibrosis. (2013) (7)
Safety Assessment of Diethanolamides as Used in Cosmetics (2013) (7)
Petriellidium (Allescheria) boydii mycetoma in an immunosuppressed host. (1983) (7)
Direct immunofluorescence testing in vasculitis—A single institution experience with Henoch‐Schönlein purpura (2018) (7)
A histochemical approach to the differentiation of lichen planus from lupus erythematosus. (1983) (7)
Amended safety assessment of tall oil acid, sodium tallate, potassium tallate, and ammonium tallate. (2009) (7)
Acantholytic Pityriasis Rubra Pilaris Associated with Imiquimod 3.75% Application (2011) (7)
Menstrual dysfunction in hirsute women. (1990) (7)
Granuloma faciale--treatment by dermabrasion. Report of a case. (1970) (7)
EBV-Negative Cutaneous Lymphomatoid Granulomatosis With Concomitant EBV-Positive Pulmonary Involvement: A Potential Diagnostic and Prognostic Pitfall. (2015) (7)
Final Report on the Safety Assessment of Piper Methysticum Leaf/Root/Stem Extract and Piper Methysticum Root Extract (2009) (7)
Diagnosis of Mycobacterium abscessus/chelonae complex cutaneous infection: Correlation of tissue culture and skin biopsy (2019) (7)
Fiber implantation for pattern baldness. Review of complications in forty-one patients. (1981) (7)
Safety Assessment of Borosilicate Glasses as Used in Cosmetics (2013) (7)
Apocrine carcinoma in situ of sweat duct origin. (2009) (7)
Angiotropic lymphoma: malignant angioendotheliomatosis. (1992) (7)
Safety Assessment of Dialkyl Sulfosuccinate Salts as Used in Cosmetics (2016) (7)
Safety Assessment of Animal- and Plant-Derived Amino Acids as Used in Cosmetics (2014) (7)
PRAME and p16 expression in acral melanocytic neoplasms. (2021) (6)
Safety Assessment of Nitrocellulose and Collodion as Used in Cosmetics (2016) (6)
Safety Assessment of Panax spp Root-Derived Ingredients as Used in Cosmetics (2015) (6)
Anetoderma arising in Reed syndrome: a case report and review of the literature (2015) (6)
Pigmented purpuric dermatosis in a young male. (1999) (6)
Prostaglandin analogue for eyebrow loss in frontal fibrosing alopecia: a case report (2019) (6)
Safety Assessment of Nylon as Used in Cosmetics (2014) (6)
Safety Assessment of Keratin and Keratin-Derived Ingredients as Used in Cosmetics (2021) (6)
Strenuous exercise and elevated creatine phosphokinase in patients taking isotretinoin. (1985) (6)
Safety Assessment of PEGs Cocamine and Related Ingredients as Used in Cosmetics (2018) (6)
Stenotrophomonas maltophila cellulitis in an immunocompromised patient presenting with purpura, diagnosed on skin biopsy (2016) (6)
Nonspecific histopathological diagnoses: the impact of partial biopsy and the need for a consensus guideline. (2014) (6)
Subcutaneous myxopapillary ependymal rest: a potential sign of spinal dysraphism. (2011) (6)
Sporotrichoid Mycobacterium marinum skin infection treated with minocycline hydrochloride. (1980) (6)
Alopecia universalis in a patient seropositive for the human immunodeficiency virus. (1993) (6)
Safety Assessment of Lecithin and Other Phosphoglycerides as Used in Cosmetics (2020) (6)
Safety Assessment of Monosaccharides, Disaccharides, and Related Ingredients as Used in Cosmetics (2019) (6)
Differentiation between AIDS-related and non-AIDS-related Kaposi's sarcoma. (1987) (6)
Histopathologic correlation of high‐risk MelaFindTM lesions: a 3‐year experience from a high‐risk pigmented lesion clinic (2018) (5)
Urticarial Vasculitis (1988) (5)
Epidermolysis bullosa of the Weber-Cockayne type with macular amyloidosis. (1985) (5)
Safety Assessment of Anthemis nobilis–Derived Ingredients as Used in Cosmetics (2017) (5)
Epidermolysis bullosa letalis and phenytoin. (1982) (5)
Safety Assessment of Silylates and Surface-Modified Siloxysilicates (2013) (5)
Response from the American Hair Research Society to "Sunscreen and Frontal Fibrosing Alopecia: A Review". (2020) (5)
Treatment for facial alopecia areata: A systematic review with evidence‐based analysis (2017) (5)
Drug‐induced alopecia areata? (2020) (5)
Eruptive neutrophilic xanthomas. (2010) (5)
Diffuse hair loss in women. (1978) (5)
Amended Safety Assessment of Hypericum Perforatum-Derived Ingredients as Used in Cosmetics (2014) (5)
Topical Therapy for the Management of Childhood Psoriasis: Part I (2008) (5)
Telogen Effl uvium (2008) (5)
Safety Assessment of PCA (2-Pyrrolidone-5-Carboxylic Acid) and Its Salts as Used in Cosmetics (2019) (5)
Chronic alopecia. Trichotillomania. (1995) (5)
Safety Assessment of Tromethamine, Aminomethyl Propanediol, and Aminoethyl Propanediol as Used in Cosmetics (2018) (5)
Safety Assessment of Panthenol, Pantothenic Acid, and Derivatives as Used in Cosmetics (2022) (5)
Efficacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss : A Multicenter (2014) (5)
Safety Assessment of Stearyl Heptanoate and Related Stearyl Alkanoates as Used in Cosmetics (2012) (5)
Safety Assessment of Sorbitan Esters as Used in Cosmetics (2019) (5)
'Myxopapillary' ependymal rest presenting as a pre-sacral skin tag. (2005) (4)
Diagnoses of hospitalized patients with skin abnormalities prompting biopsy by consulting dermatologists: A 3‐year review from a tertiary care center (2019) (4)
Safety Assessment of Formic Acid and Sodium Formate as Used in Cosmetics (2016) (4)
Congenital lymphedema of genitalia and extremities. (1984) (4)
New perspectives on acne (1995) (4)
Safety Assessment of Synthetic Fluorphlogopite as Used in Cosmetics (2015) (4)
Safety Assessment of Tin(IV) Oxide as Used in Cosmetics (2014) (4)
Donor skin allograft survival after bone marrow transplantation: Case report and systematic review of the literature☆. (2019) (4)
Safety Assessment of Citrus Fruit-Derived Ingredients as Used in Cosmetics (2021) (4)
Safety Assessment of Saccharide Esters as Used in Cosmetics (2021) (4)
How to Manage Herpes in Active Patients. (1994) (4)
Safety Assessment of Magnesium Sulfate as Used in Cosmetics (2018) (4)
Amended Safety Assessment of Chamomilla recutita-Derived Ingredients as Used in Cosmetics (2018) (4)
Histopathologic changes in skin after photochemotherapy. (1977) (4)
Diffuse dermal histiocytosis. A variant of generalized granuloma annulare. (1991) (4)
Development and qualification of a machine learning algorithm for automated hair counting (2021) (4)
Safety Assessment of Ethanolamides as Used in Cosmetics (2015) (4)
Disease Progression in Cutaneous Squamous Cell Carcinoma Patients With Satellitosis and In-transit Metastasis (2021) (4)
Cutaneous Adnexal Cylindroma of Breast: Epithelial Immunoreactivities for GATA-3, Mammaglobin, and E-Cadherin Do Not Equate to a Mammary Ductal Neoplasm (2018) (4)
Safety Assessment of Monoglyceryl Monoesters as Used in Cosmetics (2020) (4)
In vivo complement C3 binding to the intercellular substance and cytoplasm of epidermal basal cells in a patient with scleroderma and inclusion body myositis. (1990) (4)
Safety Assessment of Fatty Acid Amidopropyl Dimethylamines as Used in Cosmetics (2019) (4)
Capnocytophaga canimorsus septicemia in an asplenic patient. (1997) (4)
ILK Index and Regrowth in Alopecia Areata. (2015) (4)
Treatment of Friction Blisters in Professional Baseball Players (2004) (4)
Final Report of the Cosmetic Ingredient Review Expert Panel On the Safety Assessment of 1,2-Glycols as Used in Cosmetics June 28, 2011 (2011) (4)
The Women’s Dermatology Society: Physicians, Leaders, Mentors (2015) (4)
Safety Assessment of Rosa canina-derived Ingredients as Used in Cosmetics (2022) (4)
Enlarging, painful scalp nodule. Proliferating trichilemmal tumor. (1988) (4)
Kaposi's sarcoma, angioimmunoblastic lymphadenopathy, and antibody to HIV-1 p24 antigen in a patient nonreactive for HIV-1 with use of ELISA. (1990) (4)
Final Amended Report On the Safety Assessment of Ethanolamine and Ethanolamine Salts as Used in Cosmetics March 27 , 2012 (2012) (4)
Amended safety assessment of sodium picramate and picramic acid. (2009) (3)
Safety Assessment of Pentaerythrityl Tetraesters as Used in Cosmetics (2015) (3)
Acneiform papules on the neck. Elastosis perforans serpiginosa (EPS). (1995) (3)
Safety Assessment of 2-Amino-4-Hydroxyethylaminoanisole and 2-Amino-4-Hydroxyethylaminoanisole Sulfate as Used in Cosmetics (2013) (3)
Hyaluronic acid synthesis in fibroblasts of pretibial myxedema. (1983) (3)
Hyalinized Neurofibromas: Not Just Rare Variants in Skin of the Female Breast. (2019) (3)
Dermatologie Problems in Athletes (1982) (3)
Treatment of chronic idiopathic urticaria with astemizole. (1989) (3)
Safety Assessment of Citrus Peel-Derived Ingredients as Used in Cosmetics (2021) (3)
Eosinophilic Esophagitis: Another Atopy-Related Alopecia Areata Trigger? (2015) (3)
Callused Feet, Thick Nails, and White Tongue (1991) (3)
Safety Assessment of Ethanolamine and Ethanolamine Salts as Used in Cosmetics (2015) (3)
Safety Assessment of Alkyl Ethylhexanoates as Used in Cosmetics (2015) (3)
The A-B-C-Ds of Sensible Sun Protection (2008) (3)
Safety Assessment of Polyaminopropyl Biguanide (Polyhexamethylene Biguanide Hydrochloride) as Used in Cosmetics (2020) (3)
Differential expression of phospho‐S6 in hair follicle tumors: Evidence of mammalian target of rapamycin pathway activation (2019) (3)
The cosmetic ingredient review self-regulatory safety program. (1991) (3)
Safety Assessment of Polysaccharide Gums as Used in Cosmetics Status : Final Report Release Date : October 22 , 2015 Panel (2015) (3)
Acanthoma fissuratum. Histopathology and review of the literature. (1979) (3)
Scalp application of antioxidants improves scalp condition and reduces hair shedding in a 24‐week randomized, double‐blind, placebo‐controlled clinical trial (2021) (3)
Recent advances in T‐cell regulation relevant to inflammatory dermatopathology (2009) (3)
Occupational alopecia or alopecia areata? (2002) (3)
Amended Safety Assessment of Methylisothiazolinone as Used in Cosmetics (2021) (3)
Prostaglandin analogue for treatment of eyebrow loss in frontal fibrosing alopecia: three cases with different outcomes (2020) (3)
Safety Assessment of Mannitol, Sorbitol, and Xylitol as Used in Cosmetics (2019) (3)
Risk of sun‐induced skin cancers in patients with alopecia areata, alopecia totalis and alopecia universalis (2018) (3)
Safety Assessment of Cross-Linked Alkyl Acrylates as Used in Cosmetics (2017) (3)
GRANULAR PARAKERATOSIS (2004) (3)
Safety Assessment of Camellia sinensis–Derived Ingredients As Used in Cosmetics (2019) (3)
Safety Assessment of Polyquaternium-22 and Polyquarternium-39 as Used in Cosmetics (2016) (3)
Natural Products for Hair Care and Treatment (2008) (3)
Seronegative dermatomyositis presenting with features of anti‐MDA5 subtype (2018) (3)
Amended Safety Assessment of Fatty Acyl Sarcosines and Sarcosinate Salts as Used in Cosmetics (2021) (2)
Multiple Erythematous Plaques With Infiltrated Borders on the Forearms (1990) (2)
Lack of an association between alopecia areata and visceral or hematopoietic cancers (2017) (2)
Utility of Cyclin D1 Immunostaining in Cutaneous Xanthogranuloma (2021) (2)
Safety Assessment of Polyene Group as Used in Cosmetics (2020) (2)
Safety Assessment of Dialkyl Malates as Used in Cosmetics (2015) (2)
Leukemia cutis presenting as a chronic herpes zoster ulceration. (1984) (2)
Long-term and short-term histopathologic changes in the skin after PUVA therapy. (1983) (2)
Role of family history in patchy alopecia areata. (2018) (2)
Safety Assessment of Barium Sulfate as Used in Cosmetics (2018) (2)
Ultrastructural and immunomorphologic study of perinuclear filaments in Merkel cell tumors. (1985) (2)
Amended Safety Assessment of Isethionate Salts as Used in Cosmetics (2017) (2)
A Clinicopathologic Analysis of 54 Cases of Cutaneous Myxoma. (2021) (2)
Safety Assessment of Avena sativa (Oat)-Derived Ingredients As Used in Cosmetics (2019) (2)
Amended Safety Assessment of Salicylic Acid and Salicylates as Used in Cosmetics (2018) (2)
Enlarging, Painful Scalp Nodule (1988) (2)
Lichen sclerosus at atrophicus. (1970) (2)
Etanercept, a TNF Antagonist for Treatment of Psoriatic Arthritis and Psoriasis (2003) (2)
Modernizing regulation of cosmetic products: Reintroduction of the Personal Care Products Safety Act. (2018) (2)
TNF-α mediated keratinocyte expression and release of matrix metalloproteinase 9: putative mechanism of pathogenesis in Stevens-Johnson syndrome/ toxic epidermal necrolysis. (2022) (2)
Multiple erythematous plaques with infiltrated borders on the forearms. Multiple keratoacanthomas. (1990) (2)
Skin Diseases of the Hands and Feet. (1994) (2)
Characterizing hair loss in the elderly: an observational study of 163 patients (2019) (2)
Safety Assessment of Ascorbyl Glucoside and Sodium Ascorbyl Glucoside as Used in Cosmetics (2019) (2)
Epidermolysis bullosa acquisita. Diagnosis by electron microscopy. (1976) (2)
Secondary Syphilis Presenting as Cutaneous T‐Cell Lymphoma in an HIV‐Positive Patient (2005) (2)
Formaldehyde and Methylene Glycol (2011) (2)
Final Report of the Cosmetic Ingredient Review Expert Panel Safety Assessment of HC Yellow No . 5 March 16 , 2004 (2004) (2)
Cutaneous complications of immunosuppressive therapy. A review of 215 renal transplant patients. (1978) (2)
Angiosarcoma of the face: report of a case. (1983) (2)
Dermatologic problems in athletes. (1982) (2)
Wood's Light Examination for Assessment in Frontal Fibrosing Alopecia: A Manoeuvre to Enhance the Hairline. (2019) (2)
Safety Assessment of Ethers and Esters of Ascorbic Acid as Used in Cosmetics (2022) (2)
Reply to effectiveness of dutasteride in large series of patients with FFA in real clinical practice. (2021) (2)
Safety Assessment of Pentaerythrityl Tetra-Di-t-Butyl Hydroxyhydrocinnamate as Used in Cosmetics (2018) (2)
Muir-Torre syndrome associated with alpha 1-antitrypsin deficiency and cutaneous vasculitis. Report of a case with exacerbation of a cutaneous neoplasm during immunosuppressive therapy. (1991) (2)
Prevention of hair growth in myocutaneous flap reconstruction. (1990) (2)
Final Amended Report on Safety Assessment on Aminomethyl Propanol and Aminomethyl Propanediol (2009) (1)
Safety Assessment of Alkyl Phosphates as Used in Cosmetics (2019) (1)
Safety Assessment of Ceramides as Used in Cosmetics (2020) (1)
Diagnostic value of CD34 and calretinin immunostaining in the diagnosis of proliferating tricholemmal tumor and trichoblastoma (2020) (1)
Safety Assessment of Citrus Plant- and Seed-Derived Ingredients as Used in Cosmetics (2021) (1)
Safety Assessment of PEG-150 Pentaerythrityl Tetrastearate as Used in Cosmetics (2018) (1)
Safety Assessment of Plant-Derived Proteins and Peptides as Used in Cosmetics (2022) (1)
Photosensitivity to drugs and soaps. (1969) (1)
Trichodystrophies: A hair-raising differential diagnosis. (2015) (1)
A Multicenter Descriptive Analysis of 270 Men with Frontal Fibrosing Alopecia and Lichen Planopilaris in the United States. (2022) (1)
The Treatment of Rosacea with Glycolic Acid (2015) (1)
Safety Assessment of Skin and Connective Tissue-Derived Proteins and Peptides as Used in Cosmetics (2022) (1)
Safety Assessment of Methyl Glucose Polyethers and Esters as Used in Cosmetics (2016) (1)
Female Hirsutism: An Enigma. Causes and Treatment of Excess Hair (1987) (1)
Safety Assessment of Soy Peptides as Used in Cosmetics (2015) (1)
Graft versus host disease in a pediatric multiple organ transplant recipient with trichohepatoenteric syndrome – a unique case report (2018) (1)
Papulosquamous disorders of the feet. (1978) (1)
Women Leaders in American Dermatology (2004) (1)
Complications of fiber implantation for baldness. (1981) (1)
Thirty Years (and More) of Hair Research Societies (2021) (1)
Final Report on the Safety Assessment of Piper Methysticum Leaf/Root/Stem Extract and Piper Methysticum Root Extract (2009) (1)
Cell cycle analysis by flow cytometry of non‐exposed, sun‐exposed, and tretinoin‐treated skin (1992) (1)
Final Report on the Safety Assessment of PPG-2 Methyl Ether, PPG-3 Methyl Ether, and PPG-2 Methyl Ether Acetate (2009) (1)
Safety Assessment of Phosphoric Acid and Its Salts as Used in Cosmetics (2021) (1)
Histiocytic medullary reticulosis presenting as Mucha-Habermann disease. (1978) (1)
Prognostic Indicators of Malignant Melanoma: Retrospective Evaluation of a Six‐Year Experience at the Cleveland Clinic (1979) (1)
Foreign body reaction mimicking perineal nodular induration (2013) (1)
Safety Assessment of Monosaccharides and Disaccharides as Used in Cosmetics (2013) (1)
Treatment of female pattern hair loss with combination therapy. (2018) (1)
Safety Assessment of Centella asiatica-Derived Ingredients as Used in Cosmetics (2023) (1)
Finasteride in Frontal Fibrosing Alopecia: Joining the Dots! (2020) (1)
Early post‐transplant cutaneous bacillary angiomatosis in a kidney recipient: Case report and review of the literature (2021) (1)
Frontal fibrosing alopecia in breast cancer patients on aromatase‐inhibitor: 2 cases (2022) (1)
Safety Assessment of Plant Polysaccharide Gums as Used in Cosmetics Status : Scientific Literature Review Release (2014) (1)
Do you use the term "dysplasia"? If so, what do you mean by it, and if not, why not? (1992) (1)
Safety Assessment of Inorganic Hydroxides as Used in Cosmetics (2021) (1)
Introduction to innovations in the immunology and clinical science of alopecia areata. (2013) (1)
Amended Safety Assessment of Persulfates as Used in Cosmetics (2022) (1)
Safety Assessment of 6-Hydroxyindole as Used in Cosmetics (2014) (1)
Safety Assessment of Citrus Flower- and Leaf-Derived Ingredients as Used in Cosmetics (2021) (1)
Safety Assessment of Nitrocellulose as Used in Cosmetics (2013) (1)
Retrospective cohort study to assess the prevalence of different factors of metabolic syndrome in central centrifugal cicatricial alopecia patients (2018) (1)
Safety Assessment of Hydroxypropyl Bis(N-Hydroxyethyl-p-Phenylenediamine) HCl as Used in Cosmetics (2016) (1)
Safety Assessment of Bis-Diglyceryl Polyacyladipate-2 and Bis-Diglyceryl Polyacyladipate-1 as Used in Cosmetics (2013) (1)
378 Treatment of severe alopecia areata with the oral Janus kinase inhibitor, tofacitinib: A retrospective chart review (2017) (1)
Dermatology days. (1990) (1)
Tentative Amended Safety Assessment Ethanolamine and Ethanolamine Salts as Used in Cosmetics December 19 , 2011 (2011) (1)
Cosmeceuticals for Hair and Nails (2010) (1)
Stump the experts. Segmental neurofibromatosis. (1994) (1)
Universal protocol for alopecia areata clinical studies. (2013) (1)
Final Amended Safety Assessment of Sodium Sulfate as Used in Cosmetics (2021) (1)
Prognostic indicators of malignant melanoma: retrospective evaluation of a six-year experience at the Cleveland Clinic. (1979) (1)
Amended Safety Assessment of Mentha piperita (Peppermint)-derived Ingredients as Used in Cosmetics (2017) (1)
Thirty years (and more) of hair research societies. (2019) (1)
Safety Assessment of PCA and Its Salts as Used in Cosmetics (2014) (1)
Hair loss: a practical approach to diagnosis. (1978) (1)
Striate palmoplantar keratoderma: a clinical and ultrastructural study. (1998) (1)
Safety Assessment of Eucalyptus globulus (Eucalyptus)-Derived Ingredients as Used in Cosmetics (2023) (0)
Clinical and Experimental Dermatology Reviewers 2011 (2012) (0)
Histopathologic diagnosis of granulocytic sarcoma. (1990) (0)
Amended Final Safety Assessment Diethanolamine and its Salts as Used in Cosmetics October 17 , 2011 (2011) (0)
Erythema Nodosum as a Drug Eruption (2015) (0)
Safety Assessment of Bisabolol as Used in Cosmetics (2015) (0)
Contents Vol. 2, 2016 (2017) (0)
Squamous Cell Carcinoma of the Nailbed: a Histopathologic Study of 12 Cases (1990) (0)
Safety Assessment of Polyether Lanolins as Used in Cosmetics (2018) (0)
Primary Cutaneous Ewing’s Sarcoma/Primitive Neuroectodermal Tumor Mimicking Malignant Eccrine Spiradenoma with 22q12 Translocation by Interphase Fluorescent in Situ Hybridization (2008) (0)
Final Safety Assessment On the Safety Assessment of Alkyl Glyceryl Ethers As Used in Cosmetics December 19 (2012) (0)
Proceedings of the Ninth World Congress for Hair Research (2015). (2017) (0)
Novel Dermatologic Uses of the Immune Response Modifier Imiquimod 5% Cream (2002) (0)
Disorders of Hair Pigmentation (2021) (0)
Amended Safety Assessment of Triglycerides as Used in Cosmetics (2022) (0)
Wells' syndrome. (1989) (0)
Measurement and comparison of various androgen levels in women with severe acne, hirsutism, and androgenic alopecia (1986) (0)
NAHRS Hair Research Symposium At the 23rd World Congress of Dermatology (2015) (0)
Safety Assessment of Isostearamidopropyl Morpholine Lactate as Used in Cosmetics (2015) (0)
8 – Non-Neoplastic Disorders of Hair (2010) (0)
Dialkyl Malates as Used in Cosmetics (2012) (0)
Callused feet, thick nails, and white tongue. Pachyonychia congenita. (1991) (0)
Synringomas on the penis (1990) (0)
Sulfated Ethoxylated Alcohols Final Report of the Amended Safety Assessment of Sodium Laureth Sulfate and Related Salts of (2010) (0)
Citric Acid and Its Inorganic Salts and Alkyl and Glycol Esters as Used in Cosmetics (2011) (0)
Actinic Reticuloid (1981) (0)
Safety Assessment of Soy-Derived Ingredients as Used in Cosmetics (2013) (0)
Collagenous Spherulosis in Benign Lichenoid Keratosis-Breaking the Monopoly of Breast Lesions. (2020) (0)
Final Report of the Cosmetic Ingredient Review Expert Panel Safety Assessment of Coal Tar March 16 , 2004 (2004) (0)
Safety Assessment of Hydrofluorocarbon 152a as Used in Cosmetics (2022) (0)
Impact of Graft Versus Host Disease on Incidence of Secondary Skin Cancers in Allogeneic Bone Marrow Transplant Recipients (2018) (0)
Final Report on the Safety Assessment of PPG-2 Methyl Ether, PPG-3 Methyl Ether, and PPG-2 Methyl Ether Acetate (2009) (0)
Patterns of Failure in Head and Neck Cutaneous Squamous Cell Carcinoma Patients with Satellitosis: A Single-Institution Experience (2020) (0)
Final Report of the Cosmetic Ingredient Review Expert Panel Amended Safety Assessment of Cellulose and Related Polymers as used in Cosmetics March 23 , 2009 (2009) (0)
Current Concepts in the Treatment of Recurrent Aphthous Stomatitis (2008) (0)
Physician-Industry Collaboration: Organizational Considerations for the Future of Innovation and Growth in Dermatology (2016) (0)
Scientific approach to the treatment of acne vulgaris. (1975) (0)
Apocrine Papillary Hidrocystoma With Mucinous Metaplasia (Goblet Cell Type): A Case Report and Review of the Literature. (2023) (0)
Safety Assessment of Xylene Sulfonic Acid, Toluene Sulfonic Acid, and Alkyl Aryl Sulfonate Hydrotropes as Used in Cosmetics (2011) (0)
Acknowledgement to Referees for Skin Appendage Disorders 2016 (2017) (0)
Safety Assessment of Cocos nucifera (Coconut)-Derived Ingredients as Used in Cosmetics (2023) (0)
Identification of foreign metallic substances inducing hyperpigmentation of skin: light microscopy, electron microscopy and x-ray energy spectroscopic examination. (1987) (0)
Androgen Excess in Alopecia Areata, an Unexpected Finding (2017) (0)
Safety Assessment of Carbonate Salts as Used in Cosmetics (2022) (0)
Efficacy of Lasers and PDT for the Treatment of Acne Vulgaris (2007) (0)
Cicatricial alopecia/lichen planopilaris-the Cleveland clinic foundation experience on evaluation, diagnosis and treatment (2004) (0)
Amended Safety Assessment of Acid Violet 43 as Used in Cosmetics (2021) (0)
Safety Assessment of Ammonium Hectorites as Used in Cosmetics (2013) (0)
The Use of Alefacept in the Treatment of Psoriasis (2003) (0)
Prevalence of Central Centrifugal Cicatricial Alopecia —Reply (2011) (0)
Is Androgen Excess Masked in Alopecia Areata Patients: A Retrospective Data Analysis of 1,587 Patients (2016) (0)
Amended Safety Assessment of Butyl Polyoxyalkylene Ethers as Used in Cosmetics (2022) (0)
Cutaneous Rosai-Dorfman Disease (2008) (0)
Safety Assessment of Hydroxyethyl-3,4-Methylenedioxyaniline HCl as Used in Cosmetics (2022) (0)
cutaneous alternariasis with suspected dissemination in a patient with sarcoidosis on immunosuppression : 3135 (2016) (0)
Safety Assessment of Hydroxystearic Acid as Used in Cosmetics (2015) (0)
Collagenous Spherulosis in Benign Lichenoid Keratosis-Breaking the Monopoly of Breast Lesions. (2020) (0)
Managing androgen excess: toward longer and better life (1990) (0)
Safety Assessment of Capryloyl Salicylic Acid as Used in Cosmetics (2019) (0)
Plasma cells and acute rejection of a near‐total face transplant: an incidental finding or an evolving plasma‐cell‐mediated rejection? (2022) (0)
The Cosmetic Ingredient Review Program (Abstract) (1992) (0)
Systemic Sarcoidosis Presenting As Cutaneous Granulomatous Vasculitis (2012) (0)
616 Updates in therapeutics for pediatric alopecia areata: A systematic review with evidence-based analysis (2019) (0)
Safety Assessment of Polyol Phosphates as Used in Cosmetics (2017) (0)
Growth hormone deficiency in a young patient with alopecia areata. (2013) (0)
Comorbid conditions in lichen planopilaris: A retrospective data analysis of 334 patients (2018) (0)
Safety Assessment of Lauriminodipropionic Acid, Sodium Lauriminodipropionate, and Disodium Lauriminodipropionate as Used in Cosmetics (2013) (0)
HMGB1 expression in SJS/TEN sera and skin (2019) (0)
Pili multigemini presenting as waxy beard hair (1990) (0)
DEA Amides as Used in Cosmetics (2011) (0)
The capillary lobule variant of radiation‐associated angiosarcoma in the setting of breast cancer: A diagnostic pitfall (2022) (0)
Is it Appropriate for Nondermatologist Physicians to Perform Skin Biopsies (2008) (0)
Comprar Clinical Protocols in Dermatopathology | Wilma F. Bergfeld | 9781842141724 | Informa Healthcare (2008) (0)
Safety Assessment of Helianthus annuus (Sunflower)-Derived Ingredients as Used in Cosmetics (2023) (0)
Sézary syndrome. (1979) (0)
Amended Safety Assessment of Malic Acid and Sodium Malate as Used in Cosmetics (2022) (0)
Safety Assessment of Ginkgo biloba-Derived Ingredients as Used in Cosmetics Status : Final Report Release Date : October 12 , 2018 Panel Meeting (2017) (0)
Intravenous Immunoglobulin: Use in Dermatology (2004) (0)
Review of complications in forty-one patients (1981) (0)
Toward optimal health: the experts discuss facial skin and related concerns in women. (2003) (0)
Exploring the association between lichen planopilaris, cardiovascular and metabolic disorders (2021) (0)
Tacrolimus Ointment (Protopic ) for Atopic Dermatitis (2004) (0)
Dilated rough endoplasmic reticulum, abnormal distribution of collagen fibril diameters and gene abnormalities as clues to the diagnosis and characterization of Ehlers-Danlos type IV (1993) (0)
Amended Final Safety Assessment Diethanolamides as Used in Cosmetics October 17, 2011 (2011) (0)
Abdominal pannus with verrucous nodules, ecchymosis, and ulcerations in the setting of lymphedema (2017) (0)
Safety Assessment of 1-Hydroxyethyl 4,5-Diamino Pyrazole Sulfate as Used in Cosmetics (2022) (0)
Physician-Industry Collaboration: Organizational Considerations for the Future of Innovation and Growth in Dermatology (2016) (0)
Atypical Spindle-Cell Neoplasm With Confusing Clinical Behavior (2017) (0)
Impact of Disease History on the Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study (2022) (0)
Amended Safety Assessment of Hydroquinone (2014) (0)
A Single Institution’s Experience With Diagnosing Acute Cellular Rejection in Facial Allotransplantation (2011) (0)
Kaposi's hemorrhagic sarcoma: two cases with unusual features. (1978) (0)
Scalp application of the antioxidant piroctone olamine reduces hair shedding in an 8‐week randomized, double‐blind, placebo‐controlled clinical study (2021) (0)
Oral and maxillofacial disease: a model for interprofessional education and care. (2020) (0)
Painful plaques and nodules on the face, neck, and right wrist of a 51-year-old man. (2005) (0)
The Treatment of Atopic Dermatitis and Other Dermatoses with Leukotriene Antagonists (2004) (0)
Safety Assessment of 2-Amino-3-Hydroxypyridine as Used in Cosmetics (2020) (0)
Vaccines for the Prevention of Human Papillomavirus Infections (2006) (0)
PRP in Combination Therapy for Hair Loss (AGA) (2021) (0)
LB940 Role of graft versus host disease in the development of secondary skin cancers in hematopoietic stem cell transplant recipients: A meta-analysis (2017) (0)
Safety Assessment of Bovine Milk Proteins and Protein Derivatives as Used in Cosmetics (2022) (0)
Extramammary myofibroblastoma of the oral cavity (2022) (0)
Derived Cosmetic Ingredients − Calendula officinalis Final Report of the Cosmetic Ingredient Review Expert Panel Amended Safety Assessment of (2010) (0)
Treatment of Postherpetic Neuralgia (2004) (0)
Glans penis primary melanoma: An uncommon diagnosis and even more uncommon presentation (2020) (0)
Amiodarone-induced linear IgA disease Briefcommunications 809 (1994) (0)
Safety Assessment of Dimethiconol and Its Esters and Reaction Products as Used in Cosmetics (2017) (0)
Safety Assessment of Trimellitic Anhydride Copolymers as Used in Cosmetics (2020) (0)
Women leaders in American dermatology. Interview by Marylou C. Thelmo, E. Dorinda Shelley, Gloria F. Graham. (2004) (0)
Safety Assessment of Alkyl PEG Sulfosuccinates as Used in Cosmetics (2015) (0)
Enlarging Ulcerated Tumor on the Back (1986) (0)
Stump the experts. Cellular dermatofibroma. (1997) (0)
Enlarging ulcerated tumor on the back. Eccrine sweat gland carcinoma (SGC)--metastatic. (1986) (0)
What is your diagnosis? Uncombable hair syndrome (pili trianguli et canaliculi). (2007) (0)
Long-term and short- term histopathologic changes in the skin a f te r P U V A therapy^ (2013) (0)
Plasma Cell-Predominant Lichen Planopilaris. (2021) (0)
Skin Infections: INFECTIONS OF THE SCALP (2009) (0)
Cutaneous signs of internal malignancy. A pictorial essay. (1986) (0)
Safety Assessment of Etidronic Acid and Salts of Etidronic Acid as Used in Cosmetics (2016) (0)
Disseminated Kaposi sarcoma in patient with immune reconstitution inflammatory syndrome (2018) (0)
The Medical Bookshelf. (1990) (0)
Acknowledgement to Referees (2018) (0)
18412 Utility of p53 immunohistochemistry in inflamed squamous lesions of the skin (2020) (0)
Tentative Report On the Safety Assessment of Panax spp . Root-Derived Ingredients as Used in Cosmetics June 12 (2012) (0)
Hair disorders. (1978) (0)
Keratosis follicularis spinulosa decalvans‐like cicatricial alopecia in a patient with cardiofaciocutaneous syndrome (2022) (0)
Final Safety Assessment 2-Amino-4-Hydroxyethylaminoanisole and its Sulfate Salt as Used in Hair Dyes January 5 , 2012 (2012) (0)
Etanercept (Enbrel )-An Update (2005) (0)
PRE-READING MATERIALS (2016) (0)
Youngest Composite Full-Face Transplant (2022) (0)
Safety Assessment of Apple-Derived Ingredients as Used in Cosmetics (2023) (0)
Drug Eruptions of the Scalp (2015) (0)
Alopecia and Thyroid Disease (2008) (0)
Dermatological Management of Human Immunodeficiency Virus (HIV) (2005) (0)
COVID-19 vaccination among patients with cicatricial alopecia: patient concerns, experiences, and treatment modifications (2023) (0)
Safety Assessment of Xanthine Alkaloids as Used in Cosmetics (2018) (0)
A Review of Systemic Retinoid Therapy for Acne and Related Conditions (2004) (0)

This paper list is powered by the following services:

Wilma Fowler Bergfeld's Academic­Influence.com Rankings

Why Is Wilma Fowler Bergfeld Influential?

Wilma Fowler Bergfeld's Published Works

Published Works

Wilma Fowler Bergfeld's AcademicInfluence.com Rankings